# HMD invests over USD 15M to ramp up syringe production for COVID-19 vaccination

Hindustan Syringes & Medical Devices (HMD) invested over USD 15 million (approx. ₹100 crore) from its own resources in May 2020 to mass produce specialty syringes for COVID-19 vaccination, followed by a second round of over ₹100 crore in 2021-22.

- Type: Investment
- Announced: 2022-05-10
- Where: Faridabad, India
- Value: $15.0M
- Status: completed
- Products: AD syringes, specialty syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hindustan Syringes and Medical Devices](https://endata.com/companies/51474.md)

## Sources

- [medicalbuyer.co.in](https://medicalbuyer.co.in/celebrating-65-years-of-success/), 2022-05-10: "HMD initiated in May 2020 an investment of over USD 15 million (approx. ₹100 crore) from their own resources, without government support to mass produce specialty syringes even before purchase orders were in sight."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.